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gestion for 18 hours, only the S arc 
remains. The faint inner arc visible in 
the pattern of the undigested type Z 
myeloma y2-globulin developed with 
the antiserum to the case II protein 
probably represents a small amount of 
normal 7S y2-globulins and the very 
faint F arc seen after 4 hours of diges- 
tion may have been derived from that 
source. 
These observations establish the ex- 
istence of major structural diSerences 
between type C and type Z myeloma 
ybglobulins which are comparable to 
the demonstrated differences in the 
type C and Z proteins in "Heavy 
(Hy2) chain" disease. These structural 
differences are reflected in greater sus- 
ceptibility to papain digestion of type Z 
than of type C proteins, and the devel- 
opment of an F' component after 
papain treatment of type C but not of 
type Z proteins. Because of the greater 
susceptibility of type Z molecules to 
papain degradation, it would be antici- 
pated that the isolated F fragment of 
papain-treated pooled normal 7S y2- 
globulin would contain exclusively type 
C molecules, and this has been dem- 
onstrated. 
Within the obvious and generally 
recognized limitations of the nomen- 
clature systems now used, the struc- 
tural differences demonstrated in these 
studies are tentatively assigned to the 
H-chains, and more specifically to the 
portion of the H-chain contained in 
the F fragment of papain-treated 75 
y2-globulin. 
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Resistance to the Chemical Stenlant, 
Apholate, in Aedes aegypti 
Abstract. lncreased resistance to the 
sterilizing ef ects of apholate was ob- 
served in two colonies of Aedes aegypti 
(L.) exposed in the larval stage of each 
generation to concentrations of apho- 
late that induced about 90 to 40 per- 
cent sterility in the eggs laid by the 
ensuiog adults. 
Since the inception of research on 
the potential of chemosterilants as ill- 
sect control agents, many persons have 
asked whether insects could develop 
resistance to the sterilizing effects of 
these compounds. On the other hand, 
because the action of certain chemo- 
sterilants influences the induction of 
dominant lethal mutations, it has been 
theorized that continued exposure to 
substerilizing dosages or to dosages 
causing only partial sterility might re- 
sult in accumulation of genetic defects 
and ultimate death of a colony. 
In 1962 efforts were initiated to 
determine whether the yellow fever 
mosquito, Aedes aegypti (L.), could 
develop resistance to apholate (1). 
Weidhaas et al. (2) had reported that 
sterility could be induced in A. aegypti 
by feeding adult mosquitoes on honey 
solution containing 0.1 percent of 
apholate. Weidhaas (3) had also dem- 
onstrated that exposure of larvae of 
A. aegypti, from the third instar to 
pupation, in water containing 10 parts 
of apholate per million produced about 
90 percent sterility in the ensuing males 
and about 50 percent sterility in fe- 
males. When both sexes were treated, 
sterility was about 98 percent. In later 
experiments at this laboratory sterility 
induced by this larval treatment some- 
times reached 100 percent. For our 
experiments in development of resist- 
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Fig. 3. Immunoelectrophoretic analyses of 
type C and type Z myeloma a2-globulins 
before and after digestion with papain for 
4 and 18 hours. 
as the F' arc is unchanged in intensity 
as compared with the pattern of the 
4-hour digest. In contrast to this be- 
havior, the case V (Z) protein, after 
4 hours of papain digestion, shows a 
marked diminution in intensity and a 
cathodal displacement of the major pre- 
cipitin arc (FS) without the develop- 
ment of an F' arc. Treatment of the 
case V (Z) protein for 18 hours de- 
stroyed all material precipitable by the 
antiserum to the case II protein. 
We then studied the comparative ef- 
fects of papain treatment on six type 
C and the two type Z myeloma y2- 
globulins. Representative results of 
these studies are shown in Fig. 3. These 
patterns were made with the antiserum 
to the case II protein, which develops 
only the F and F' arcs, and an anti- 
serum to normal 7S y2-globulin ( anti- 
y2) which also demonstrates the S 
(slow) fragment. The type C myeloma 
y2-globulin, after 4 hours of papain di- 
gestion, shows strong F and F' arcs in 
addition to an S arc. After 18 hours of 
digestion, these three arcs are still visi- 
ble, although attenuated, and it is evi- 
dent that the F arc has been diminished 
to a greater degree than the F' and S 
arcs. In contrast to this behavior, the 
type Z myeloma y2-globulins after 4 
hours of papain treatment, shows a 
prominent S arc, only a very faint trace 
of an F arc, and no F' arc. After di- 
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ance, selection pressure was exerted by 
treatment in the larval stage. 
Two different colonies of A. aegypti 
were subjected to selection. Treatment 
of the first colony began in December 
1962, and a second colony was sub- 
jected to selection pressure beginning 
in July 1963. 
The strain of A. aegypti used in 
both experiments was from our regular 
colony, maintained at this laboratory 
for more than 20 years without delib- 
erate exposure to insecticides. In each 
generation several hundred third-instar 
larvae were placed in shallow exposure 
panslthat contained 1 liter of a solu- 
tion of apholate (S ppm) in tapwater. 
In the first experiment the number 
of larvae in each pan varied, depend- 
ing on the quantity available; in the 
second experiment 300 larvae were al- 
ways used in each pan. After 24 hours, 
food consisting of powdered dog bis- 
cuit was added, and larvae were al- 
lowed to continue development in the 
treated water until they reached the 
pupal stage. Pupae were removed to 
untreated water, and emerging adults 
were allowed to remain together in a 
screen cage for about S days to permit 
mating. Females were then given a 
blood meal on a guinea pig. A day 
later a container which had been lined 
with filter paper, and containing water 
to keep the filter paper damp, was 
placed in the cage for oviposition. Eggs 
deposited by all the laying females 
Table 1. Sterility of eggs from a colony of 
Aedes aegypti exposed in the larval stage of 
each generation to selection pressure with 
apholate and from treated and untreated mos- 
quitoes from the regular colony. 
Gener- SterilitY of mos- Sterility 
ation Concen- to apholate from 
apho- apholate Apho- Reg untreated 
late (ppm) late ular regular 
colony colony Colony cOlony 
(%) (%) (%) 
Experiment I 
Parent 5 96 2 
1 5 89 20 
2 5 75 48 
3 5 59 3 
4 5 46 6 
5 15 72 2 
Expe7^iment 2 
Parent 5 91 6 
1 5 85 1 
2 5 90 0 
3 5 82 1 
4 5 85 2 
5 5 77 19 
6 5 38 15 
7 5 52 84 8 
8 5 50 93 17 
9 10 81 100 4 
10 10 88 100 18 
1 1 10 59 100 4 
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were used to produce the next gener- 
ation of the colony. In addition, the 
percentage hatch of eggs laid in each 
generation was determined separately. 
In the first experiment females were 
individually confined for oviposition, 
and the percentage hatch was calcu- 
lated for all eggs laid. In each gener- 
ation 1000 to 5000 eggs were checked 
for sterility. In the second experiment 
a sample of about 200 eggs, taken at 
random from eggs laid by all females 
about 1 week after deposition, was 
used to determine percentage hatch. 
A complete cycle from third instar to 
third instar required about 3 weeks. 
In the second experiment, beginning 
with the F7 generation of the apholate- 
treated colony, larvae from the reg- 
ular colony were treated with the same 
dosage of apholate as those in the 
experimental colony. This procedure 
provided a direct comparison between 
the sterility induced in the selected and 
in the unselected colonies. The per- 
centage sterility in eggs from untreated 
mosquitoes from the regular colony 
was also determined in each generation 
(Table 1 ) . 
In the first experiment sterility of 
eggs from females exposed to S ppm 
of apholate gradually declined from 96 
percent in the parent generation to 
46 percent in the 4 generation. Lar- 
vae from the F6 generation were ex- 
posed to 15 ppm, a dosage which 
usually causes complete or almost 
complete sterility. Resulting sterility of 
eggs from the females was 72 percent 
or 24 percent less than that obtained 
with the initial selection dosage of 5 
ppm. The percentage sterility in the 
control colony ranged from 2 percent 
to 48 percent (average 13.5 percent); 
however, in 4 out of the-6 hatchings 
sterility was 6 percent or less. 
In the second experiment, sterility 
ranged from 77 percent to 91 percent 
for the parent and first five genera- 
tions, but decreased in the next three 
generations (38 percent to 52 percent). 
In the F9 generation the selection 
concentration was increased to 10 ppm. 
This concentration caused 81 percent 
and 88 percent sterility in the next two 
generations, but in the F generation 
sterility dropped to 59 percent. At this 
selection concentration, complete steril- 
ity was obtained with treated mos- 
quitoes from the regular colony. In 
addition, these females produced far 
fewer eggs than females from the apho- 
late colony. Sterility among untreated 
control females ranged from O per- 
cent to 19 percent. 
These data indicate that A. aegypti 
can develop resistance to apholate. 
The degree of resistance encountered 
to date is not great, probably between 
four and five times that of the normal 
strain. 
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Polydactylism in the Ofspring 
of Mice Injected with 
5-Bromodeoxyuridine 
Abstract. The intraperitoneal injec- 
tion of multiple doses of .S-bromode- 
oxyuridine (BUDR) into pregnant 
mice produced abnormalities limited to 
the h.ind limbs of the offspring. This 
efgf ect is probably a result of a meta- 
bolic lesion. When injected into new- 
born mice, BUDR did! noEt increase the 
incidence of tumors. 
A mutagen, 5-bromodeoxyuridine 
(BUDR), was investigated for possible 
somatic effects on hybrid mice. The 
potential carcinogenicity of this muta- 
gen was also studied by direct treat- 
ment of newborn inbred mice. The 
BUDR was selected because its muta- 
genic action is well understood ( 1 ), 
and because it entexs the DNA of 
mammalian cells while S-bromouracil 
does not (2 ) . 
Mice of strains A and C3H-MF were 
used. The breeding mice were 3 to 5 
months old and all the females were 
virgin. The somatic effect of BUDR 
was studied in hybrid embryos of 
C3H-MF males and strain A females. 
At the time of discovery of vaginal 
plug, considered as zero time in gesta- 
tion period, the pregnant females were 
isolated in individual cages. The drug 
was dissolved in isotonic saline, and a 
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